NEWS - May 8, 2025 Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025 Read more
NEWS - Apr 28, 2025 Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025 Read more
NEWS - Mar 27, 2025 Relmada Therapeutics Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update Read more
NEWS - Mar 26, 2025 Relmada Therapeutics to Report Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025 Read more
NEWS - Mar 25, 2025 Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd. Read more
NEWS - Feb 6, 2025 Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB Read more
